The knockdown of SREBP1 in HCC cells has revealed that BCAT2 expression is also significantly reduced, thereby confirming that the level of BCAT2 expression is also regulated via the AMPK-SREBP1 signaling pathway in HCC cells. This evidence concerns the gene BCAT2 and hepatocellular carcinoma.